Where is AstraZeneca headquartered?
In Cambridge, United Kingdom.
Gain a deeper understanding of how AstraZeneca is organized around the world. Founded in 1999, AstraZeneca operates a network of 467 subsidiaries across 76 countries, with 119 in the United States (25.5%), 66 in India (14.1%), and 44 in the United Kingdom (9.4%). Together these three countries account for 49.0% of the companies owned by AstraZeneca.
AstraZeneca
Company Hierarchy
| Company | Location | Founded | Employees | Revenue (USD) | Legal Type | CEO | Website | Category Code | Category Description | # in Group | Local HQ Name | Local HQ City | Local HQ Country | National HQ Name | National HQ City | Global HQ Name | Global HQ City | Global HQ Country | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astrazeneca PLCAstrazeneca PLCGlobal Headquarter | Trumpington, Unitedkingdom | 1999 | 95,100 | $58.7B | Corporation | Marcus Wallenberg | astrazeneca.com | 2834 | Pharmaceutical Preparations | 467 | ASTRAZENECA PLC | CAMBRIDGE | England | ASTRAZENECA PLC | CAMBRIDGE | ASTRAZENECA PLC | CAMBRIDGE | England | ||
Astrazeneca Asia - Regional OfficeAstrazeneca Asia - Regional OfficeNational HQ | Singapore, Singapore | 100 | $4.9M | Mike Henry | 2834 | Pharmaceutical Preparations | 467 | ASTRAZENECA PLC | CAMBRIDGE | England | ASTRAZENECA ASIA - REGIONAL OFFICE | SINGAPORE | ASTRAZENECA PLC | CAMBRIDGE | England | |||||
Astrazeneca S.a.c.v.Astrazeneca S.a.c.v.National HQ | Costarica | 8 | $273K | Corporation | 7389 | Business Services, Not Elsewhere Classified | 467 | ASTRAZENECA PLC | CAMBRIDGE | England | Astrazeneca S.A.C.V. | ASTRAZENECA PLC | CAMBRIDGE | England | ||||||
EsobiotecEsobiotecNational HQ | Mont-saint-guibert, Belgium | 2020 | 19 | $1.5M | Corporation | Carsten Linnemann | 8731 | Commercial Physical and Biological Research | 467 | ASTRAZENECA PLC | CAMBRIDGE | England | Esobiotec | Mont-Saint-Guibert | ASTRAZENECA PLC | CAMBRIDGE | England | |||
EsobiotecEsobiotec | Mont-saint-guibert, Belgium | 2020 | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 467 | Esobiotec | Mont-Saint-Guibert | Belgium | Esobiotec | Mont-Saint-Guibert | ASTRAZENECA PLC | CAMBRIDGE | England | |||||||
Astrazeneca LuxembourgAstrazeneca LuxembourgNational HQ | Luxembourg, Luxemburg | 1983 | 1 | $22.7M | Corporation | Luk Vranken | astrazeneca.com/country-sites/luxembourg.html | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 467 | ASTRAZENECA PLC | CAMBRIDGE | England | AstraZeneca Luxembourg | LUXEMBOURG | ASTRAZENECA PLC | CAMBRIDGE | England | ||
Sixpeaks Bio AGSixpeaks Bio AGNational HQ | Basilea, Switzerland | 2022 | 18 | $3.0M | Corporation | Mark Purcell | 8731 | Commercial Physical and Biological Research | 467 | ASTRAZENECA PLC | CAMBRIDGE | England | SixPeaks Bio AG | BASEL | ASTRAZENECA PLC | CAMBRIDGE | England | |||
Astrazeneca AGAstrazeneca AGNational HQ | Baar, Switzerland | 1999 | 124 | $15.1M | Corporation | Florian Saur | astrazeneca.ch | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 467 | ASTRAZENECA PLC | CAMBRIDGE | England | AstraZeneca AG | BAAR | ASTRAZENECA PLC | CAMBRIDGE | England | ||
Evinova AGEvinova AGLocal HQ | Baar, Switzerland | 2023 | 300 | $2.7M | Corporation | Cristina Ortega Duran | evinova.com | 7371 | Computer Programming Services | 467 | AstraZeneca AG | BAAR | Switzerland | AstraZeneca AG | BAAR | ASTRAZENECA PLC | CAMBRIDGE | England | ||
Evinova Poland Sp Z O OEvinova Poland Sp Z O ONational HQ | Warszawa, Poland | 2024 | 1 | $90K | Corporation | Kurpiewska Mariola Elzbieta | 7371 | Computer Programming Services | 467 | Evinova AG | BAAR | Switzerland | EVINOVA POLAND SP Z O O | Warszawa | ASTRAZENECA PLC | CAMBRIDGE | England | |||
Shanghai Aweiluo Medical Technology CO., LTDShanghai Aweiluo Medical Technology CO., LTDNational HQ | Shanghai, China | 2024 | 41 | $2.0M | Foreign company | Jie Zhang | 7373 | Computer Integrated Systems Design | 467 | Evinova AG | BAAR | Switzerland | Shanghai Aweiluo Medical Technology Co., Ltd | Shanghai | ASTRAZENECA PLC | CAMBRIDGE | England | |||
Evinova Spain SL.Evinova Spain SL.National HQ | Madrid, Spain | 2024 | 3 | $206K | Corporation | Anies Escude, Jose Miguel | 7379 | Computer Related Services, Not Elsewhere Classified | 467 | Evinova AG | BAAR | Switzerland | EVINOVA SPAIN SL. | MADRID | ASTRAZENECA PLC | CAMBRIDGE | England | |||
Evinova LIMITEDEvinova LIMITED | Trumpington, Unitedkingdom | 2024 | Corporation | Adam Mcarthur | 9999 | Nonclassifiable Establishments | 467 | Evinova AG | BAAR | Switzerland | ASTRAZENECA PLC | CAMBRIDGE | ASTRAZENECA PLC | CAMBRIDGE | England | |||||
Astrazeneca PLCAstrazeneca PLC | Stonehouse, Unitedkingdom | astrazeneca.com | 8732 | Commercial Economic, Sociological, and Educational Research | 467 | ASTRAZENECA PLC | CAMBRIDGE | England | ASTRAZENECA PLC | CAMBRIDGE | ASTRAZENECA PLC | CAMBRIDGE | England | |||||||
Astrazeneca PLCAstrazeneca PLC | Moss Nook, Unitedkingdom | astrazeneca.com | 8732 | Commercial Economic, Sociological, and Educational Research | 467 | ASTRAZENECA PLC | CAMBRIDGE | England | ASTRAZENECA PLC | CAMBRIDGE | ASTRAZENECA PLC | CAMBRIDGE | England | |||||||
AstrazenecaAstrazenecaNational HQ | Courbevoie, France | 1973 | 991 | $1.1B | Corporation | Auriane Marie Francoise Canochancel | astrazeneca.fr | 2834 | Pharmaceutical Preparations | 467 | ASTRAZENECA PLC | CAMBRIDGE | England | ASTRAZENECA | COURBEVOIE | ASTRAZENECA PLC | CAMBRIDGE | England | ||
Amolyt PharmaAmolyt Pharma | Écully, France | 2014 | 20 | $4.0M | Corporation | Anne-laure Marie Dupont | amolytpharma.com | 8731 | Commercial Physical and Biological Research | 467 | ASTRAZENECA | COURBEVOIE | France | ASTRAZENECA | COURBEVOIE | ASTRAZENECA PLC | CAMBRIDGE | England | ||
Astrazeneca Dunkerque ProductionAstrazeneca Dunkerque Production | Dunkerque, France | 2003 | 500 | $2.2B | Partnership of unknown type | Anne-sophie Bellaert | astrazeneca.com | 2834 | Pharmaceutical Preparations | 467 | ASTRAZENECA | COURBEVOIE | France | ASTRAZENECA | COURBEVOIE | ASTRAZENECA PLC | CAMBRIDGE | England | ||
AstrazenecaAstrazeneca | Rueil-malmaison, France | 2000 | Rachid Izzar | astrazeneca.fr | 2834 | Pharmaceutical Preparations | 467 | ASTRAZENECA | COURBEVOIE | France | ASTRAZENECA | COURBEVOIE | ASTRAZENECA PLC | CAMBRIDGE | England | |||||
Astrazeneca ABAstrazeneca ABNational HQ | Södertälje, Sweden | 1913 | 5,000 | $20.5B | Corporation | Per David Alfredsson | astrazeneca.se/om-oss/verksamheten-i-sverige/sodertalje.html | 2834 | Pharmaceutical Preparations | 467 | ASTRAZENECA PLC | CAMBRIDGE | England | Astrazeneca AB | SODERTÄLJE | ASTRAZENECA PLC | CAMBRIDGE | England | ||
Astrazeneca India Private LIMITEDAstrazeneca India Private LIMITEDNational HQ | Chennai, India | 1986 | 4,250 | $236.0M | Corporation | Padmanabhan Sivakumar | aastrazen.com | 2834 | Pharmaceutical Preparations | 467 | Astrazeneca AB | SODERTÄLJE | Sweden | ASTRAZENECA INDIA PRIVATE LIMITED | Chennai | ASTRAZENECA PLC | CAMBRIDGE | England | ||
Astrazeneca India Private LIMITEDAstrazeneca India Private LIMITED | New Delhi, India | 2001 | 7371 | Computer Programming Services | 467 | ASTRAZENECA INDIA PRIVATE LIMITED | Chennai | India | ASTRAZENECA INDIA PRIVATE LIMITED | Chennai | ASTRAZENECA PLC | CAMBRIDGE | England | |||||||
Astrazeneca India Private LIMITEDAstrazeneca India Private LIMITED | Bengaluru, India | 2009 | Sanjeev Panchal | 7371 | Computer Programming Services | 467 | ASTRAZENECA INDIA PRIVATE LIMITED | Chennai | India | ASTRAZENECA INDIA PRIVATE LIMITED | Chennai | ASTRAZENECA PLC | CAMBRIDGE | England | ||||||
Astrazeneca India Private LIMITEDAstrazeneca India Private LIMITED | Bengaluru, India | 2009 | 7371 | Computer Programming Services | 467 | ASTRAZENECA INDIA PRIVATE LIMITED | Chennai | India | ASTRAZENECA INDIA PRIVATE LIMITED | Chennai | ASTRAZENECA PLC | CAMBRIDGE | England | |||||||
Astrazeneca India Private LIMITEDAstrazeneca India Private LIMITED | Bengaluru, India | 2001 | 7371 | Computer Programming Services | 467 | ASTRAZENECA INDIA PRIVATE LIMITED | Chennai | India | ASTRAZENECA INDIA PRIVATE LIMITED | Chennai | ASTRAZENECA PLC | CAMBRIDGE | England | |||||||
Get 1,000 subsidiaries free
AstraZeneca’s ownership network is one of more than 41 million corporate hierarchies in our company ownership database. It maps parent companies, subsidiaries and ultimate beneficial owners (UBO), showing how companies are structured and who owns whom, with verified data across 200 countries and jurisdictions. Explore how the dataset works and request a tailored sample.
In Cambridge, United Kingdom.
AstraZeneca plc is publicly traded with no single majority shareholder.
Yes. AstraZeneca plc is incorporated in the UK (company no. 0341901830).
AstraZeneca employs tens of thousands of people globally.
Global data. Local insights.
Explore more about global company data, subsidiaries, and corporate hierarchies in our latest blog posts.
A global ultimate in a corporate family refers to the highest-level parent company in a...
Company Registries in the EU & North America A practical guide for compliance, KYC and...
What Are Company Family Members? A company family members refers to a group of interrelated...
Corporate family tree
Knowing who owns and controls a company shows how its business operates worldwide. Our corporate hierarchy data allows you to track the links between parent companies, subsidiaries, and shareholders, revealing the full picture of AstraZeneca’s global group. Whether for compliance checks, market research, or better CRM data, this insight offers clarity on AstraZeneca and other large corporations. Our verified ownership data covers millions of companies in many countries, giving you a clear view of how companies like AstraZeneca connect across borders and industries.
At CompanyData.com, we use a three-level model to map companies like AstraZeneca: Global, National, and Local headquarters. This setup shows how each part of the company fits into the bigger group.
Every company has a unique ID, so you can connect subsidiaries to their parent groups, trace ownership, and use the data in your systems.
Control is based on majority ownership. When one company owns over 50% of another, we list it as a controlled subsidiary. This method helps describe clear ownership and control within AstraZeneca’s global network. It offers a clear picture of large corporate groups and can be used for any multinational.
Understanding the full structure shows real decision-makers in AstraZeneca’s group. It simplifies tasks like compliance checks, risk studies, or merger analysis. With more than 475 subsidiaries spread across over 70 countries—including 119 subsidiaries in the USA, 64 in India, and 22 in the Netherlands—CompanyData.com provides a clear and accurate map of AstraZeneca’s worldwide operations. Our data supports teams working with complex companies and global corporate structures.

CompanyData.com provides trusted data on global companies like AstraZeneca, delivering verified insights into their corporate structures and subsidiaries. This helps businesses enrich CRM data, support compliance processes, and deliver market intelligence and analysis. We offer free samples for evaluation; larger datasets covering up to 1,000 companies are available to vetted corporate buyers with a clear use case and an active company website. For contact or lead lists, please see our Company Data Platform.
Tell us about your use case or data challenge, and our team will send you a tailored ownership data sample within 24 hours.
AstraZeneca is a global biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. The company specializes in key therapy areas such as oncology, cardiovascular, renal, metabolism, respiratory, and immunology. AstraZeneca was formed in 1999 and is headquartered in Cambridge, United Kingdom. The company operates in multiple countries worldwide, including a strong presence in the USA, China, India, and across Europe.
AstraZeneca develops innovative medicines and invests heavily in research. Their focus includes:
AstraZeneca operates through numerous subsidiaries and affiliates worldwide. The company is active in over 100 countries with key subsidiaries in the United States (119), China (21), India (64), and Netherlands (22), among others. These subsidiaries support local markets in research, manufacturing, and sales.
With a reported revenue of $38.68 billion, AstraZeneca is a leader in the pharmaceutical industry. Its wide portfolio and ongoing research investments contribute to its steady financial growth.
AstraZeneca is dedicated to sustainability and aims to reduce its environmental impact by increasing energy efficiency, minimizing waste, and focusing on green innovation.
The company faces challenges such as regulatory environments, competition, and pricing pressures. However, its focus on strong R&D and expanding emerging markets presents growth opportunities.
AstraZeneca is a major player in the biopharmaceutical sector with a global footprint and a diverse portfolio. Its ownership structure includes hundreds of subsidiaries across many countries to support its operations and growth. For the latest data on AstraZeneca and its global subsidiaries, resources like CompanyData.com provide detailed and verified information.
You can access AstraZeneca company data through API, bulk files, or the Bold Platform. We create custom datasets based on your target countries, industries, and company profiles. After you share your criteria, our experts prepare a tailored dataset and send a free quote with record counts and sample data within 24 hours. Once approved, we deliver your data quickly in your preferred format — via Excel, API, bulk file, or directly in the Bold Platform.
If you need company data from any organization or industry, CompanyData.com provides complete global coverage. You’ll get accurate, verified business information across every country and sector. Simply tell us what you’re looking for, and our experts will prepare a custom dataset that fits your goals. Within 24 hours, you’ll receive a free quote, record count, and sample data. Once approved, we deliver your data fast — via Excel, API, bulk file, or directly in the Bold Platform.
The price of our AstraZeneca company data varies based on your chosen details and delivery method. Whether you need a list of subsidiaries or a full dataset via API or bulk files, we offer flexible pricing to suit your needs. You can request a free quote and record count within 24 hours — our team will provide transparent pricing and a free sample of 10 company contacts. At CompanyData.com, you only pay for the verified global data you need.
At CompanyData.com, we offer secure and flexible payment options for purchasing company data, including credit cards, bank transfer, and PayPal. All payments are processed safely, and invoices are provided. For larger or ongoing access, we also support subscription billing and custom invoicing. Need a special arrangement? Contact our sales team — we’re happy to help.
At CompanyData.com, you can access detailed, verified data on AstraZeneca plc and all its subsidiaries, updated daily. This includes company names, registration details, locations, industry classifications, financial indicators, and key contacts. You can download the data via the Bold Platform, API, or bulk file delivery. Our database offers 100% worldwide company coverage, ensuring complete and accurate insights.
At CompanyData.com, our data comes from verified global business sources to ensure accuracy and full coverage. We combine official registers, financial filings, LEI records, trusted partners, and verified company websites. All data is cross-checked and validated by our experts, ensuring it’s accurate, up-to-date, and GDPR-compliant.
Tell us your target group, and we’ll send you a free quote and a tailored company ownership dataset — sample included. Call +31 20 705 236 or email sales@companydata.com. Ready to order? Simply reply to the quote, and CompanyData.com delivers your dataset in CSV or Excel within 24 hours.